Topics

Cerevel Puts Tavapadon Into Phase III for Parkinson’s

04:04 EST 15 Jan 2020 | SCRIP

The company, launched in October 2018 with neuroscience programs spun out from Pfizer and supported by $350m from Bain, believes...

      

Related Stories

 

Original Article: Cerevel Puts Tavapadon Into Phase III for Parkinson’s

NEXT ARTICLE

More From BioPortfolio on "Cerevel Puts Tavapadon Into Phase III for Parkinson’s"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...